Correlation of Clinical and Pathological Parameters with the Diversity and Genetic Evolution of Breast Cancer in Senegalese Women
F. Mbaye, A. Dem, M. Fall, E. S. Mbaye, G. Diop, R. Ndiaye, M. S. Niang, A. Dieye, M. Sembene
Journal of Advances in Medicine and Medical Research · pp. 2627–2638 · Published 22 Feb 2014
10.9734/BJMMR/2014/6859Abstract
Aims: The purpose of this study was to assess the hypothesis that genetic diversity of breast cancer is related to clinical and pathological tumors characteristics. Study Design: Representative sequences of mitochondrial Cytochrome b gene of cancerous tissues were analyzed to determinate diversity and genetic evolution of breast tumors in Senegalese women. Place and Duration of Study: Department of biology Animal (University Cheikh Anta Diop), laboratory of molecular biology (IRD-CBGP), 2011-2013. Methodology: Genetic diversity of breast tumors in 57 Senegalese patients was estimated by analyzing sequences of the Cytochrome b mitochondrial coding gene. The Cytochrome b sequences from cancerous tissues were aligned using BioEdit version 7.0.8. Number of polymorphic sites, parsimony informative sites, the rate of transitions/transversions and the nucleotide frequency were calculated using MEGA 5.05. Genetic distance (d) was calculated with MEGA 5 using the Kimura 2-parameter (K2P) model. The index of genetic differentiation (Fst) used to describe the distribution of the genetic diversity between sub-groups was calculated with the software DnaSP version 10.5.01. The significance level (P-value) was 0.05. Results: Analyses have revealed a high score of haplotype (Hd=0.991+/-0.008) and nucleotide diversity (Pi=0.15650+/-0.01326). Statistical correlations have shown a positive association between the risk factors (age of the patients, appearance of the first menstruation beyond 12 years, number of gestation) and nucleotide diversity of tumors (P<0.0001). Statistical analyses based on t-test showed a positive association between age, date of onset of the first menstruation and nucleotide diversity (Pi), between healthy and cancerous tissues for each patient (P<0.0001). Conclusion: Our results have shown an important genetic diversity in breast tumors. A strong genetic differentiation was noted depending on the number of gestations.
Cited by 1
MohamedMze Ahmed, F. Mbaye, Binta Keneme · 2017
Related research
- Does Pain Adversely Affect the Quality of Life in Hospitalized Cancer Patients? — shares topic coverage
- Complementary Medicine Intervention in Breast Cancer Patients with Pain — shares topic coverage
- Use of Performance Status Score for Cytotoxic Chemotherapy among Surgeons in a Tertiary Hospital, Southern Nigeria — shares topic coverage
- Breast Self Examination and Cancer Awareness among Female Staff in Federal Medical Center, Yenagoa, Bayelsa State (Knowledge and Practice) — shares topic coverage
- Assessment of Cancer Risk from Fluorscopic Bile Duct Examinations at Sanjiwani Hospital, Gianyar — shares topic coverage
Article metrics
Real usage data collected on this platform.
26
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.